Verrica Pharmaceuticals Stock Price History
| VRCA Stock | USD 0.92 0.04 4.17% |
Below is the normalized historical share price chart for Verrica Pharmaceuticals extending back to June 15, 2018. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Verrica Pharmaceuticals stands at 0.92, as last reported on the 13th of November 2024, with the highest price reaching 0.99 and the lowest price hitting 0.87 during the day.
If you're considering investing in Verrica Stock, it is important to understand the factors that can impact its price. Verrica Pharmaceuticals owns Efficiency Ratio (i.e., Sharpe Ratio) of -0.14, which indicates the firm had a -0.14% return per unit of risk over the last 3 months. Verrica Pharmaceuticals exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please validate Verrica Pharmaceuticals' Coefficient Of Variation of (539.83), risk adjusted performance of (0.13), and Variance of 109.07 to confirm the risk estimate we provide.
At present, Verrica Pharmaceuticals' Total Stockholder Equity is projected to increase significantly based on the last few years of reporting. The current year's Stock Based Compensation is expected to grow to about 15.1 M, whereas Common Stock Shares Outstanding is forecasted to decline to about 29 M. . At present, Verrica Pharmaceuticals' Price To Sales Ratio is projected to increase significantly based on the last few years of reporting. The current year's Price Book Value Ratio is expected to grow to 17.63, whereas Price Earnings Ratio is forecasted to decline to (5.20). Verrica Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 15th of June 2018 | 200 Day MA 5.1998 | 50 Day MA 1.5498 | Beta 1.457 |
Verrica |
Sharpe Ratio = -0.1403
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | VRCA |
Estimated Market Risk
| 9.42 actual daily | 83 83% of assets are less volatile |
Expected Return
| -1.32 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.14 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Verrica Pharmaceuticals is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Verrica Pharmaceuticals by adding Verrica Pharmaceuticals to a well-diversified portfolio.
Price Book 238.5425 | Enterprise Value Ebitda (11.70) | Price Sales 4.7626 | Shares Float 19.7 M | Wall Street Target Price 9.25 |
Verrica Pharmaceuticals Stock Price History Chart
There are several ways to analyze Verrica Stock price data. The simplest method is using a basic Verrica candlestick price chart, which shows Verrica Pharmaceuticals price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
| Highest Price | August 19, 2024 | 2.96 |
| Lowest Price | November 7, 2024 | 0.7 |
Verrica Pharmaceuticals November 13, 2024 Stock Price Synopsis
Various analyses of Verrica Pharmaceuticals' daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell Verrica Stock. It can be used to describe the percentage change in the price of Verrica Pharmaceuticals from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of Verrica Stock.| Verrica Pharmaceuticals Price Daily Balance Of Power | (0.33) | |
| Verrica Pharmaceuticals Price Rate Of Daily Change | 0.96 | |
| Verrica Pharmaceuticals Price Action Indicator | (0.03) | |
| Verrica Pharmaceuticals Accumulation Distribution | 76,364 |
Verrica Pharmaceuticals November 13, 2024 Stock Price Analysis
Verrica Stock Price History Data
The price series of Verrica Pharmaceuticals for the period between Thu, Aug 15, 2024 and Wed, Nov 13, 2024 has a statistical range of 4.57 with a coefficient of variation of 43.96. The daily prices for the period are distributed with arithmetic mean of 1.88. The median price for the last 90 days is 1.68.| Open | High | Low | Close | Volume | ||
| 11/12/2024 | 0.99 | 0.99 | 0.87 | 0.92 | 630,003 | |
| 11/11/2024 | 0.83 | 0.98 | 0.83 | 0.96 | 1,221,387 | |
| 11/08/2024 | 0.72 | 0.83 | 0.71 | 0.83 | 1,608,273 | |
| 11/07/2024 | 0.75 | 0.77 | 0.70 | 0.70 | 1,432,189 | |
| 11/06/2024 | 0.83 | 0.87 | 0.74 | 0.75 | 1,795,364 | |
| 11/05/2024 | 0.93 | 0.94 | 0.75 | 0.80 | 3,640,634 | |
| 11/04/2024 | 1.53 | 1.54 | 1.43 | 1.43 | 331,166 | |
| 11/01/2024 | 1.43 | 1.56 | 1.41 | 1.53 | 484,041 | |
| 10/31/2024 | 1.60 | 1.62 | 1.40 | 1.40 | 265,442 | |
| 10/30/2024 | 1.66 | 1.74 | 1.60 | 1.60 | 310,442 | |
| 10/29/2024 | 1.53 | 1.71 | 1.53 | 1.68 | 288,118 | |
| 10/28/2024 | 1.49 | 1.64 | 1.49 | 1.56 | 430,184 | |
| 10/25/2024 | 1.48 | 1.52 | 1.42 | 1.51 | 317,520 | |
| 10/24/2024 | 1.54 | 1.60 | 1.46 | 1.50 | 323,097 | |
| 10/23/2024 | 1.59 | 1.59 | 1.49 | 1.51 | 340,078 | |
| 10/22/2024 | 1.56 | 1.62 | 1.51 | 1.59 | 302,397 | |
| 10/21/2024 | 1.60 | 1.60 | 1.50 | 1.57 | 343,094 | |
| 10/18/2024 | 1.49 | 1.60 | 1.47 | 1.60 | 361,906 | |
| 10/17/2024 | 1.51 | 1.53 | 1.43 | 1.46 | 321,531 | |
| 10/16/2024 | 1.39 | 1.66 | 1.38 | 1.51 | 792,900 | |
| 10/15/2024 | 1.41 | 1.48 | 1.37 | 1.39 | 276,634 | |
| 10/14/2024 | 1.35 | 1.44 | 1.31 | 1.42 | 457,752 | |
| 10/11/2024 | 1.28 | 1.36 | 1.27 | 1.34 | 308,007 | |
| 10/10/2024 | 1.26 | 1.35 | 1.25 | 1.29 | 259,019 | |
| 10/09/2024 | 1.30 | 1.34 | 1.22 | 1.28 | 480,800 | |
| 10/08/2024 | 1.35 | 1.41 | 1.28 | 1.28 | 428,878 | |
| 10/07/2024 | 1.32 | 1.46 | 1.27 | 1.34 | 1,086,195 | |
| 10/04/2024 | 1.45 | 1.54 | 1.31 | 1.31 | 1,723,873 | |
| 10/03/2024 | 1.10 | 1.58 | 1.10 | 1.45 | 11,103,683 | |
| 10/02/2024 | 1.36 | 1.40 | 1.04 | 1.11 | 1,496,729 | |
| 10/01/2024 | 1.48 | 1.48 | 1.36 | 1.37 | 828,980 | |
| 09/30/2024 | 1.65 | 1.68 | 1.45 | 1.45 | 1,213,197 | |
| 09/27/2024 | 1.69 | 1.75 | 1.65 | 1.69 | 371,344 | |
| 09/26/2024 | 1.69 | 1.75 | 1.66 | 1.68 | 348,526 | |
| 09/25/2024 | 1.76 | 1.77 | 1.65 | 1.66 | 432,112 | |
| 09/24/2024 | 1.79 | 1.82 | 1.70 | 1.76 | 645,014 | |
| 09/23/2024 | 1.82 | 1.82 | 1.75 | 1.75 | 276,605 | |
| 09/20/2024 | 1.95 | 1.95 | 1.81 | 1.81 | 425,346 | |
| 09/19/2024 | 1.92 | 2.00 | 1.87 | 1.94 | 372,582 | |
| 09/18/2024 | 1.79 | 1.96 | 1.78 | 1.85 | 729,225 | |
| 09/17/2024 | 1.90 | 1.96 | 1.77 | 1.77 | 593,677 | |
| 09/16/2024 | 1.97 | 2.01 | 1.88 | 1.89 | 230,791 | |
| 09/13/2024 | 1.97 | 2.06 | 1.94 | 1.97 | 368,080 | |
| 09/12/2024 | 1.93 | 2.03 | 1.93 | 1.94 | 310,941 | |
| 09/11/2024 | 1.90 | 2.09 | 1.89 | 1.93 | 685,086 | |
| 09/10/2024 | 1.90 | 1.96 | 1.85 | 1.95 | 519,849 | |
| 09/09/2024 | 1.94 | 2.02 | 1.90 | 1.91 | 564,200 | |
| 09/06/2024 | 2.07 | 2.14 | 1.89 | 1.91 | 1,280,597 | |
| 09/05/2024 | 2.30 | 2.31 | 2.08 | 2.08 | 799,021 | |
| 09/04/2024 | 2.18 | 2.44 | 2.15 | 2.30 | 734,358 | |
| 09/03/2024 | 2.35 | 2.35 | 2.11 | 2.18 | 484,374 | |
| 08/30/2024 | 2.42 | 2.49 | 2.28 | 2.35 | 1,023,120 | |
| 08/29/2024 | 2.33 | 2.52 | 2.02 | 2.44 | 5,021,567 | |
| 08/28/2024 | 2.44 | 2.50 | 2.30 | 2.33 | 2,575,000 | |
| 08/27/2024 | 2.57 | 2.58 | 2.38 | 2.46 | 809,290 | |
| 08/26/2024 | 2.80 | 2.83 | 2.53 | 2.57 | 1,156,100 | |
| 08/23/2024 | 2.75 | 2.97 | 2.75 | 2.82 | 886,002 | |
| 08/22/2024 | 2.90 | 3.02 | 2.76 | 2.79 | 797,853 | |
| 08/21/2024 | 2.87 | 2.92 | 2.75 | 2.91 | 676,883 | |
| 08/20/2024 | 2.96 | 2.96 | 2.66 | 2.83 | 725,963 | |
| 08/19/2024 | 2.80 | 3.09 | 2.63 | 2.96 | 1,442,929 |
About Verrica Pharmaceuticals Stock history
Verrica Pharmaceuticals investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Verrica is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Verrica Pharmaceuticals will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Verrica Pharmaceuticals stock prices may prove useful in developing a viable investing in Verrica Pharmaceuticals
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 45.3 M | 29 M | |
| Net Loss | -22 M | -23.1 M |
Verrica Pharmaceuticals Quarterly Net Working Capital |
|
Verrica Pharmaceuticals Stock Technical Analysis
Verrica Pharmaceuticals technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Did you try this?
Run Aroon Oscillator Now
Aroon OscillatorAnalyze current equity momentum using Aroon Oscillator and other momentum ratios |
| All Next | Launch Module |
Verrica Pharmaceuticals Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Verrica Pharmaceuticals' price direction in advance. Along with the technical and fundamental analysis of Verrica Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Verrica to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | (0.13) | |||
| Jensen Alpha | (1.97) | |||
| Total Risk Alpha | (4.10) | |||
| Treynor Ratio | (11.67) |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Complementary Tools for Verrica Stock analysis
When running Verrica Pharmaceuticals' price analysis, check to measure Verrica Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Verrica Pharmaceuticals is operating at the current time. Most of Verrica Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Verrica Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Verrica Pharmaceuticals' price. Additionally, you may evaluate how the addition of Verrica Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Money Managers Screen money managers from public funds and ETFs managed around the world |